Ackman Still Doesn’t See Valeant Clearly
Nominally Quebecois specialty pharma company seeks CEO. Fixer-upper. Share price, board and business in shambles. Some took the news that Valeant CEO Mike Pearson plans to step down as a sign the troubled pharmaceutical firm might break up. Continue reading